Speaking of SurgOnc
Podcasts
"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.
"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.
Location:
United States
Genres:
Podcasts
Description:
"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.
Language:
English
Contact:
8474271400
Episodes
COVID-19 Is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States
5/10/2022
Rick Greene, MD, and Adam Berger, MD, discuss a shift away from nonurgent and preventative medical care due to the pandemic, related changes in presentation of melanoma patients in surgical clinics, and the likely impact on melanoma diagnoses and prognoses.
Dr. Berger is author of, “COVID-19 Is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States.” Dr. Berger is Chief of Melanoma for the multidisciplinary Melanoma and Soft Tissue Surgical Oncology...
Duration:00:12:45
Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation
4/19/2022
Rick Greene, MD, and Nicole Lopez, MD, discuss a watch and wait approach to treating rectal cancer with complete clinical response after neoadjuvant therapy, which reduces overall costs and increases effectiveness compared with radical resection. Dr. Lopez is author of, “Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation.”
Dr. Lopez is Director of the UC San Diego National Accreditation Program for...
Duration:00:10:47
A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction
3/15/2022
In this episode of Speaking of SurgOnc, Rick Greene, MD, and Mary Gemignani, MD, discuss quality of life outcomes associated with surgical management of early-stage breast cancer. Dr. Gemignani is author of the article, “A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction.” Dr. Gemignani is Professor of Surgery, Weill Cornell Medical College, and Attending Surgeon, Director Breast Surgery Fellowship, Memorial Sloan...
Duration:00:11:18
Cultural Complications Curriculum: Applicability to Surgical Oncology Programs and Practices
2/8/2022
In this episode of Speaking of SurgOnc, Rick Greene, MD and Lesly A. Dossett, MD, discuss meeting the needs of an increasingly culturally and racially diverse patient population, as well as support and recruitment of a surgical oncology workforce that better represents all minority groups. Dr. Dossett is author of the article, “Cultural Complications Curriculum: Applicability to Surgical Oncology Programs and Practices.”
Dr. Dossett is Associate Professor of Surgery, Chief of the Division...
Duration:00:12:06
Introducing the Ongoing Clinical Trials in the Surgical Oncology Series
1/11/2022
In this episode of Speaking of SurgOnc, Rick Greene, MD and Jonathan M. Hernandez, MD, discuss the need for surgical oncologists to keep informed of ongoing research in multiple arenas and the launch of a new editorial series to address current challenges in meeting this need. Dr. Hernandez is author of the editorial, “Introducing the Ongoing Clinical Trials in the Surgical Oncology Series.”
Dr. Hernandez is Associate Professor of Surgery with the Uniformed Services University of the Health...
Duration:00:11:27
Landmark Series on Disparities in Surgical Oncology: Melanoma
12/14/2021
In this episode of Speaking of SurgOnc, Rick Greene, MD and John H. Stewart, MD, discuss the unequal burden of melanoma between Blacks and whites in the United States and the differences in access to melanoma care. Dr. Stewart is author of the article, “Landmark Series on Disparities in Surgical Oncology: Melanoma.”
Dr. Stewart is Professor of Surgery, LSU Health New Orleans School of Medicine, and is Center Director of the LSU Health New Orleans/LCMC Health Cancer Center, New Orleans, LA.
Duration:00:13:48
Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control
11/9/2021
In this episode of Speaking of SurgOnc, Rick Greene, MD and Kristin E. Rojas, MD, discuss the implementation of an opioid-sparing multimodal analgesia protocol for lumpectomy patients for pain management without a routine opioid prescription. Dr. Rojas is author of the article, “Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control.”
Dr. Rojas is Assistant Professor of Surgery at the Sylvester Comprehensive Cancer Center,...
Duration:00:11:18
Impact of the COVID-19 Pandemic on Cancer Clinical Trials
10/12/2021
In this episode of Speaking of SurgOnc®, Rick Greene, MD, and Judy Boughey, MD, discuss the impact of COVID-19 on US clinical research at the local, cooperative group, and national level. Dr. Boughey is the author of the article, “Impact of the COVID-19 Pandemic on Cancer Clinical Trials.”
Dr. Judy Boughey is Professor of Surgery in Division of Breast and Melanoma Surgical Oncology, Department of Surgery at Mayo Clinic, Rochester, MN.
Duration:00:12:35
Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
8/10/2021
Rick Greene, MD, and Elisa Port, MD, discuss surgeon adherence to NCCN guidelines and patterns of testing in newly diagnosed breast cancer patients. Dr. Port is author of, “Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?”
Dr. Port is Chief of Breast Surgery and Director of the Dubin Breast Center, Mount Sinai Hospital, and Professor of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
Duration:00:11:29
Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines
7/13/2021
Rick Greene, MD and Nancy Cho, MD discuss the impact of the 2015 American Thyroid Association guideline change on clinical practice in low-risk differentiated thyroid cancer, specifically regarding the rate of completion thyroidectomy. Dr. Cho is author of the article, “Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines.”
Dr. Cho is Associate Surgeon, Brigham and Women's Hospital and Dana-Farber Cancer Institute, and Assistant Professor of...
Duration:00:11:15
Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons
6/15/2021
Rick Greene, MD, and Courtney Balentine, MD, discuss race and gender disparities in the time from initial diagnosis of hyperparathyroidism to treatment with parathyroidectomy. Dr. Balentine is author of, "Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons."
Dr. Balentine is Assistant Professor of General and Endocrine Surgery, and Co-Director of the UTSW Surgical Center for Outcomes, Implementation and Novel...
Duration:00:08:37
Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer
5/21/2021
Rick Greene, MD and Vivian Strong, MD discuss factors associated with quality-of-life recovery after gastrectomy. Dr. Strong is author of “Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer.”
Dr. Strong is the Iris Cantor Endowed Chair and Attending Surgeon, Memorial Sloan Kettering Cancer Center; Professor of Surgery and Associate Dean, Weill Cornell Medical College of Cornell University; and Vice Chair of Surgery for Surgical Innovations and Outcomes, Memorial...
Duration:00:17:37
Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma
3/21/2021
Rick Greene, MD, and Melissa Hogg, MD, discuss the relationship of serum CA19-9 to other markers of response, and the related thresholds correlating to outcomes, following neoadjuvant therapy for pancreatic adenocarcinoma. Dr. Hogg is author of the article, “Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma.”
Dr. Hogg is the Director of HPB Surgery and Director of Robotic Training for Grainger Lab at the Northshore...
Duration:00:12:49
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change
2/9/2021
Rick Greene, MD, and Ken Tanabe, MD, discuss the need for surgical oncologists to remain focused on providing optimal care for our cancer patients while managing the demands that the COVID-19 pandemic continues to impose. Dr. Tanabe is author of, "Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change."
Dr. Tanabe is a Professor of Surgery at Harvard Medical School and Chief, Division of Gastrointestinal and Oncologic Surgery,...
Duration:00:12:48
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade
1/11/2021
Rick Greene, MD and Charlotte Ariyan, MD, PhD, discuss survival outcomes in patients with metastatic melanoma who were selected for surgery following checkpoint blockade. Dr. Ariyan is author of, “Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.”
Dr. Ariyan is Associate Professor of Surgery, Weill Cornell Medical College, and a Surgeon with clinical expertise in melanoma and soft tissue sarcoma, at Memorial Sloan Kettering Cancer...
Duration:00:11:41
Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial
12/8/2020
Rick Greene, MD and Katie Egan, MD discuss the use of an educational intervention to decrease opioid consumption among breast surgery patients. Dr. Egan is author of the article, “Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial.”
Dr. Egan is Plastic and Reconstructive Surgery Resident at The University of Kansas Medical Center in Kansas City, KS.
Duration:00:07:40
The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer
11/10/2020
Rick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen receptor-positive breast cancer. Dr. Weiss is author of “The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.”
Dr. Weiss is Assistant Professor of Surgery at Harvard Medical School, Boston, MA.
Duration:00:13:45
The Landmark Series: Neuroendocrine Tumor Liver Metastases
10/13/2020
Rick Greene, MD, and Alexandra Gangi, MD and James Howe, MD, discuss current data regarding management of neuroendocrine liver metastases and future areas for study. Dr. Gangi and Dr. Howe are authors of “The Landmark Series: Neuroendocrine Tumor Liver Metastases.”
Dr. Gangi is Assistant Professor of Surgery in the Department of Surgical Oncology and the Director of the Gastrointestinal Tumor Program at Cedars-Sinai, Los Angeles, CA. Dr. James Howe is Professor of Surgery and Division Head...
Duration:00:11:57
Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies
8/11/2020
Rick Greene, MD and Giorgos Karakousis, MD discuss the impact of immune checkpoint and BRAF/MEK pathway inhibitors on outcomes and melanoma care at a national population level in patients diagnosed with clinical stage III melanoma. Dr. Karakousis is author of, “Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies.”
Dr. Karakousis is Associate Professor of Surgery at the Hospital of the University of Pennsylvania, Philadelphia, PA.
Duration:00:07:51
Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases
7/14/2020
Rick Greene, MD, and Michael D’Angelica, MD discuss the relationship between hepatic parenchymal disease and recurrence after colorectal liver metastases resection, which has not been well defined. Dr. D’Angelica is author of, “Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.”
Dr. D’Angelica holds the Enid A. Haupt Chair in Surgery at Memorial Sloan Kettering Cancer Center and is Professor of Surgery at Weill Medical College...
Duration:00:06:58